![Stephen Thomas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Thomas
Direktor/Vorstandsmitglied bei
CLIMB BIO, INC.
Vermögen: 2 Mio $ am 30.06.2026
Profil
Stephen Thomas is the founder of Sera Medicines LLC, founded in 2023, serving as Chief Executive Officer & Director.
Dr. Thomas was the founder of Climb Bio Operating, Inc., founded in 2023, and served as Chief Executive Officer & Director from 2023 to 2024.
Dr. Thomas was the founder of Ichorion Therapeutics, Inc., founded in 2017, and served as Chief Scientific Officer from 2017 to 2018.
Dr. Thomas currently works as Director at Climb Bio, Inc. starting in 2024.
Former jobs include Chief Executive Officer & Director at Navigator Medicines, Inc. from 2024 to 2025, Chief Scientific Officer at ValenzaBio, Inc. from 2020 to 2023, and Vice President & Head-Discovery at Avalo Therapeutics, Inc. from 2018 to 2020.
Education includes graduate and doctorate degrees from The Trustees of Columbia University in The City of New York and an undergraduate degree from Rensselaer Polytechnic Institute.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CLIMB BIO, INC. 0,27 % | 05.06.2026 | 154 657 ( 0,27 % ) | 2 Mio $ | 30.06.2026 |
Aktive Positionen von Stephen Thomas
| Unternehmen | Position | Beginn |
|---|---|---|
| CLIMB BIO, INC. | Direktor/Vorstandsmitglied | 27.06.2024 |
Ehemalige bekannte Positionen von Stephen Thomas
| Unternehmen | Position | Ende |
|---|---|---|
ValenzaBio, Inc.
 ValenzaBio, Inc. BiotechnologyHealth Technology Develops treatment options for patients with autoimmune and inflammatory diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
| AVALO THERAPEUTICS, INC. | Corporate Officer/Principal | 01.02.2020 |
Ichorion Therapeutics, Inc.
 Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceutical products | Gründer | 01.09.2018 |
Ausbildung von Stephen Thomas
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Ichorion Therapeutics, Inc.
Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceutical products | Health Technology |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology Develops treatment options for patients with autoimmune and inflammatory diseases | Health Technology |
